PolarityTE

PolarityTE is a biotechnology company that develops regenerative tissue products and biomaterials. PolarityTE's first regenerative tissue product is SkinTE®. PolarityTE has an open Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for SkinTE® and is currently conducting the first of two pivotal studies required to support a Biologics License Application (BLA) for the indication of chronic cutaneous ulcers. SkinTE® is for investigational use only.